Blar i NTNU Open på forfatter "Myklebust, Tor Åge"
-
Reliability of preoperative MRI findings in patients with lumbar spinal stenosis
Banitalebi, Hasan; Espeland, Ansgar; Anvar, Masoud D; Hermansen, Erland; Hellum, Christian; Brox, Jens Ivar; Myklebust, Tor Åge; Indrekvam, Kari; Brisby, Helena; Weber, Clemens; Aaen, Jørn Ståle; Austevoll, Ivar Magne; Grundnes, Oliver; Negård, Anne (Peer reviewed; Journal article, 2022)Background Magnetic Resonance Imaging (MRI) is an important tool in preoperative evaluation of patients with lumbar spinal stenosis (LSS). Reported reliability of various MRI findings in LSS varies from fair to excellent. ... -
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study
Langseth, Øystein Olstad; Myklebust, Tor Åge; Johannessen, Tom Børge; Hjertner, Øyvind; Waage, Anders (Peer reviewed; Journal article, 2022)Objectives We conducted a population-based study to assess the risk for multiple myeloma (MM) and other cancers in first- and second-degree relatives of MM patients, and to investigate whether evidence of anticipation is ... -
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial
Aksnessæther, Bjørg Yksnøy; Myklebust, Tor Åge; Solberg, Arne; Klepp, Olbjørn; Skovlund, Eva; Hoff, Solveig Roth; Fosså, Sophie Dorothea; Widmark, Anders; Lund, Jo-Åsmund (Peer reviewed; Journal article, 2019)Background Curative radiation therapy (RT) constitutes a cornerstone in prostate cancer (PC) treatment. We present long-term follow-up estimates for second cancer (SC) risk and overall survival (OS) in patients randomized ... -
Second cancers in radically treated Norwegian prostate cancer patients
Aksnessæther, Bjørg Yksnøy; Lund, Jo-Åsmund; Myklebust, Tor Åge; Klepp, Olbjørn; Skovlund, Eva; Hoff, Solveig Roth; Solberg, Arne (Journal article; Peer reviewed, 2019)Introduction: The aim of this registry-based cohort study was to estimate second cancer (SC) risk following radical prostate cancer (PC) treatment and evaluate if the risk was influenced by radiotherapy. Materials and ... -
T1 bladder cancer in Norway: treatment and survival
Blindheim, Augun Jodis; Fosså, Sophie Dorothea; Babigumira, Ronnie; Myklebust, Tor Åge; Haug, Erik Skaaheim; Arum, Carl-Jørgen; Kulle, Bettina (Peer reviewed; Journal article, 2020)Aim: Evaluation of treatment and survival of pT1 stage (T1) bladder cancer (BC) patients diagnosed with transitional cell carcinoma of the urinary bladder in Norway. Material and methods: According to the Cancer Registry ... -
Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
Hellesnes, Ragnhild; Myklebust, Tor Åge; Fosså, Sophie Dorothea; Bremnes, Roy M.; Karlsdottir, Åsa; Kvammen, Øivind; Tandstad, Torgrim; Wilsgaard, Tom; Negaard, Helene Francisca Stigter; Haugnes, Hege Sagstuen (Peer reviewed; Journal article, 2021)PURPOSE Using complete information regarding testicular cancer (TC) treatment burden, this study aimed to investigate cause-specific non-TC mortality with impact on previous treatment with platinum-based chemotherapy (PBCT) ... -
Treatment and 30-day mortality after myocardial infarction in prostate cancer patients: A population-based study from Norway
Forster, Rachel Bedenis; Kjellstadli, Camilla; Myklebust, Tor Åge; Egeland, Grace M.; Sulo, Gerhard; Bjørge, Tone; Bønaa, Kaare Harald; Juliusson, Pétur Benedikt; Kvåle, Rune (Peer reviewed; Journal article, 2022)Introduction: There is limited knowledge about the use of invasive treatment and mortality after acute myocardial infarction (AMI) in prostate cancer (PCa) patients. We therefore wanted to compare rates of invasive treatment ...